AKT1 and cancer: By activating growth inhibitory pathways in tumor cells, Cur-loaded nanoparticles might downregulate growth factors and their receptors, including NF-B activity, signaling channels for PI3K-AKT activity, and therefore block cancer cell development (Wang J et al., 2016).